FOI release

FOI-PAR for Amphotericin B SUN

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2024/00645

Received 22 October 2024

Published 22 November 2024

Request

We seek your assistance under provision of Freedom of Information for the following product: Amphotericin B SUN liposomal 50 mg powder for dispersion for infusion is first authorised on 17/04/2024 in UK. MA number is PL 14894/0784 and is granted to company named Sun Pharma UK Ltd. Though it was registered in April 2024, Public assessment report for the same is still not available on MHRA website. Can you please provide the PAR for our reference.

Response

see attached

Documents

• FOI2024_00645 redacted for publication.pdf (103.4 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.